# Apathy in Dementia Methylphenidate Trial (ADMET)

> **NCT01117181** · PHASE2 · COMPLETED · sponsor: **Johns Hopkins Bloomberg School of Public Health** · enrollment: 60 (actual)

## Conditions studied

- Apathy
- Alzheimer's Disease

## Interventions

- **DRUG:** Methylphenidate
- **DRUG:** placebo
- **OTHER:** Psychosocial intervention

## Key facts

- **NCT ID:** NCT01117181
- **Lead sponsor:** Johns Hopkins Bloomberg School of Public Health
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-06
- **Primary completion:** 2012-08
- **Final completion:** 2012-08
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2018-06-12

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01117181

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01117181, "Apathy in Dementia Methylphenidate Trial (ADMET)". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT01117181. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*